Diabetes Insipidus, Neurogenic clinical trials
The registry lists 27 studies for Diabetes Insipidus, Neurogenic across more than 10 countries. 12 are recruiting or about to start. 16 of them are mainly about Diabetes Insipidus, Neurogenic (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.
Get an email when these change. Save the Diabetes Insipidus, Neurogenic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Basel, Switzerland (11) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (3) · Finch Research and Development LLC. (2) · Elizabeth Austen Lawson (2) · Ferring Pharmaceuticals (1) · Hospital Universitario 12 de Octubre (1) · Christian Lodberg Hvas (1) · Seoul National University Hospital (1)
What is being tested here
Drugs under test in Diabetes Insipidus, Neurogenic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7
- Dec 2026Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls · University Hospital, Basel, Switzerland
- Dec 2026Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls · University Hospital, Basel, Switzerland
- Dec 2026The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU · Children's Hospital of Fudan University
- Feb 2027Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency · University Hospital, Basel, Switzerland
- Feb 2027Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls · University Hospital, Basel, Switzerland
- Apr 2027Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease · Massachusetts General Hospital
- Jun 2027Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency · Elizabeth Austen Lawson
Who these studies take
Of the 11 Diabetes Insipidus, Neurogenic studies recruiting now, 8 (73%) set no upper age limit and 3 (27%) stop at 75 or younger. 2 (18%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (45%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (18%) | 2 (18%) |
| 18 | 11 (100%) | 11 (100%) |
| 30 | 9 (82%) | 9 (82%) |
| 40 | 9 (82%) | 9 (82%) |
| 50 | 9 (82%) | 9 (82%) |
| 65 | 8 (73%) | 8 (73%) |
| 75 | 8 (73%) | 8 (73%) |
| 85 | 8 (73%) | 8 (73%) |
Across all 27 studies, recruiting or not: 41% stop at 75 or younger and 33% at 65; 19% take children; 0% are for women only and 0% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin DeficiencyRecruitingNCT04789148Phase 11 country
- Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary DiseaseRecruitingNCT07568509Early Phase 11 country
- Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyRecruitingNCT07361263Not applicable1 country
- Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeRecruitingNCT07569861Not applicable1 country
- Oxytocin Substitution Therapy in Patients With Central Diabetes InsipidusRecruitingNCT06036004Phase 23 countries
- The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICURecruitingNCT067420601 country
- Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation TechnologyRecruitingNCT07276152Not applicable1 country
- Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy ControlsRecruitingNCT06808516Phase 21 country
- Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsRecruitingNCT06676774Phase 21 country
- Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsRecruitingNCT06789705Not applicable1 country
- Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in ChildrenNot yet recruitingNCT06604975Not applicable1 country
- Registry of Patients in Shock Treated With VasopressinRecruitingNCT064229751 country
- Fecal Microbiota Transplantation for Early Clostridioides Difficile InfectionCompletedNCT04885946Not applicable1 country
- Identifying Oxytocin Deficiency in Adults With Pituitary DiseaseCompletedNCT06460948Early Phase 11 country
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)CompletedNCT04897802Phase 41 country
- Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)CompletedNCT06542198Not applicable1 country
- Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia SyndromeCompletedNCT05890690Not applicable1 country
- Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)CompletedNCT05319301Not applicable1 country
- Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)CompletedNCT04902235Phase 41 country
- Electrophysiology of the Human Pituitary GlandTerminatedNCT05338125Not applicable1 country
- Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffCompletedNCT03110133Phase 22 countries
- Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile InfectionCompletedNCT03497806Phase 22 countries
- Copeptin After a Subcutaneous Stimulation With Glucagon in AdultsCompletedNCT04550520Not applicable1 country
- Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy ControlsCompletedNCT04648137Not applicable1 country
- Seoul National University Pituitary Disease Cohort StudyStatus unknownNCT034746011 country
- A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).CompletedNCT01280188Phase 31 country
- Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes InsipidusCompletedNCT000043631 country